Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation

PHASE2CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions
Cerebral HemorrhageAtrial Fibrillation
Interventions
DRUG

Apixaban

DRUG

Aspirin

DRUG

Carbasalate calcium

DRUG

Clopidogrel

DRUG

Dipyridamole

OTHER

No antithrombotic treatment

Trial Locations (16)

Unknown

Amsterdam UMC, Amsterdam

OLVG, Amsterdam

Gelre Ziekenhuizen, Apeldoorn

Rijnstate, Arnhem

Amphia Ziekenhuis, Breda

Albert Schweitzer Ziekenhuis, Dordrecht

Medisch Spectrum Twente, Enschede

University Medical Center Groningen, Groningen

Zuyderland Ziekenhuis, Heerlen

Leiden University Medical Center, Leiden

Maastricht University Medical Center, Maastricht

Radboud University Medical Center, Nijmegen

Erasmus MC, Rotterdam

Haaglanden MC, The Hague

Elisabeth-Tweesteden Ziekenhuis, Tilburg

3584CX

UMC Utrecht, Utrecht

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Dutch Heart Foundation

OTHER

collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

UMC Utrecht

OTHER

NCT02565693 - Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation | Biotech Hunter | Biotech Hunter